May 16 (Reuters) - Hikma Pharmaceuticals Plc HIK.L raised its full-year revenue forecast, saying its generic antibiotic doxycycline was generating revenue ahead of its expectations.

The company said it expected group revenue to rise about 13 percent in 2013, up from previous forecast of around 10 percent

ID:nRS9MBWNd

Hikma reported revenue of $1.11 billion in 2012.

(Reporting by Ankur Banerjee in Bangalore; Editing by Don Sebastian)

((ankur.banerjee@thomsonreuters.com)(within U.S. +1 646 223 8780, outside U.S. +91 80 6749 6132)(Reuters Messaging: Reuters Messaging: ankur.banerjee.thomsonreuters.com@reuters.net))

Keywords: HIKMA OUTLOOK/